AT320847B - Verfahren zur Herstellung von neuen 3-Carbamoyloxymethylcephalosporinderivaten - Google Patents

Verfahren zur Herstellung von neuen 3-Carbamoyloxymethylcephalosporinderivaten

Info

Publication number
AT320847B
AT320847B AT58072A AT58072A AT320847B AT 320847 B AT320847 B AT 320847B AT 58072 A AT58072 A AT 58072A AT 58072 A AT58072 A AT 58072A AT 320847 B AT320847 B AT 320847B
Authority
AT
Austria
Prior art keywords
carbamoyloxymethylcephalosporin
derivatives
preparation
new
carbamoyloxymethylcephalosporin derivatives
Prior art date
Application number
AT58072A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB329571A external-priority patent/GB1350772A/en
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of AT320847B publication Critical patent/AT320847B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/577-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with a further substituent in position 7, e.g. cephamycines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
AT58072A 1971-01-27 1972-01-25 Verfahren zur Herstellung von neuen 3-Carbamoyloxymethylcephalosporinderivaten AT320847B (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB329571A GB1350772A (en) 1971-01-27 1971-01-27 Antibiotics and processes for their production
GB2852271 1971-06-17
GB3965471 1971-08-24

Publications (1)

Publication Number Publication Date
AT320847B true AT320847B (de) 1975-02-25

Family

ID=27254239

Family Applications (1)

Application Number Title Priority Date Filing Date
AT58072A AT320847B (de) 1971-01-27 1972-01-25 Verfahren zur Herstellung von neuen 3-Carbamoyloxymethylcephalosporinderivaten

Country Status (4)

Country Link
AT (1) AT320847B (de)
IL (1) IL38620A (de)
NL (1) NL7200469A (de)
PH (1) PH10742A (de)

Also Published As

Publication number Publication date
NL7200469A (en) 1972-07-31
IL38620A (en) 1975-04-25
PH10742A (en) 1977-09-01

Similar Documents

Publication Publication Date Title
AT313268B (de) Verfahren zur Herstellung von neuen 5-Aroylpyrrolderivaten
AT322550B (de) Verfahren zur herstellung von neuen isothiocyanobenzazolen
AT318610B (de) Verfahren zur Herstellung von neuen Carboxamidotetrazol-Derivaten
AT319607B (de) Verfahren zur Herstellung von neuen Polyepoxydpolysiloxanverbindungen
AT316763B (de) Verfahren zur Herstellung von neuen Adenosinderivaten
AT321476B (de) Verfahren zur Herstellung von neuen Adenosinderivaten
AT314534B (de) Verfahren zur Herstellung von neuen Oxadiazolonderivaten
AT329531B (de) Verfahren zur herstellung von neuen hydroxycitronensaure-gamma-lactonderivaten
AT309398B (de) Verfahren zur Herstellung von neuen 1-Crotonylcyclohex-2-enen
AT315201B (de) Verfahren zur Herstellung von neuen α-Alkoxy-ω-siloxanolen
AT317891B (de) Verfahren zur Herstellung von neuen substituierten 3-Benzylpyridinverbindungen
AT315837B (de) Verfahren zur Herstellung von neuen Thiazolidinderivaten
AT319245B (de) Verfahren zur Herstellung von neuen Pyridinderivaten
AT317212B (de) Verfahren zur Herstellung von neuen Benzopyranderivaten
AT319953B (de) Verfahren zur Herstellung von neuen substituierten Isazolopyrimidinen
AT316748B (de) Verfahren zur Herstellung von neuen Lincomycinderivaten
AT315196B (de) Verfahren zur Herstellung von neuen 6-Hydroxy-dihydro-uracilen
AT321309B (de) Verfahren zur Herstellung von neuen substituierten Isoxazolopyrimidinen
AT310771B (de) Verfahren zur Herstellung von neuen Phosphinyl-alkylaminobenzophenonen
AT315373B (de) Verfahren zur Herstellung von neuen 3-Formylrifamycin-SV-Derivaten
AT319203B (de) Verfahren zur Herstellung von neuen N-Acetyl-S-(3-aryl-3-oxopropyl)-cysteinderivaten
AT313897B (de) Verfahren zur Herstellung von neuen Oxadiazolonderivaten
AT310761B (de) Verfahren zur Herstellung von neuen Triazolobenzodiazepin-5N-oxyd-Derivaten
AT317903B (de) Verfahren zur Herstellung von neuen Pyrimidotriazinen
AT320662B (de) Verfahren zur Herstellung von neuen Carbamoyloximen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee